An Introduction to Retina/Vitreous
Retinal diseases are a leading cause of vision loss and blindness, but advances in imaging and treatment have improved patient outcomes over recent years. The introduction of OCT-A has had a big impact on the diagnosis and management of conditions such as diabetic macular oedema (DMO) and diabetic retinopathy. The treatment landscape of these conditions was revolutionized following the introduction of anti-VEGF therapies, and research into longer-lasting, multi-targeted treatments is currently underway.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Optical Lens Tinting—A Review of its Functional Mechanism, Efficacy, and Applications
US Ophthalmic Review. 2019;12(2):85–7
Optical lens filtration therapy began with FL-41 lenses that were developed in the late 1980s and first reported in 1991 by Wilkins and Wilkinson.1 They were originally designed to improve workplace productivity by reducing eye strain and headaches induced by fluorescent lighting. They were designed to allow only 10% light filtration from 400–550 nm with a […]
Verteporfin Photodynamic Therapy for the Treatment of Choroidal Conditions—An Overview
US Ophthalmic Review, 2019;12(2):69–78
Photodynamic therapy (PDT) is a technique involving the use of a photosensitizing agent that, when activated by light of a specific wavelength, causes localized and selective tissue damage.1,2 Initially developed to treat tumor cells using tumor-localizing photosensitizing agents (e.g., Photofrin®, Pinnacle Biologics, Chicago, IL USA),1 ophthalmic PDT was developed in the 1990s to treat conditions such as […]
Post-cataract Cystoid Macular Oedema Prevention – Update 2019
European Ophthalmic Review. 2019;13(1): 37–43 DOI: https://doi.org/10.17925/EOR.2019.13.1.37
Various options for the prevention of pseudophakic cystoid macular oedema (PCMO) have been offered. Nonsteroidal anti-inflammatory drugs (NSAIDs) seem to be beneficial in preventing postoperative inflammation; however, there is lack of evidence for long-term benefit after cataract surgery. What is more, topical NSAID preparations are difficult to compare, as studies differ in inclusion criteria, patient […]
Jost Jonas, EURETINA 2019 – Myopia: Epidemiology, Histology & Clinics
It was fantastic to meet up with Jost Jonas (Ruprecht-Karls University) to discuss the Keynote Lecture ‘Myopia: Epidemiology, Histology & Clinics’ he presented at this year’s meeting. Support: No funding was received in the production of this video. Disclosures: Jost Jonas has nothing to disclose in relation to this video.
Michael Abramoff, EURETINA 2019 – AI-based diabetic retinopathy screening
AI was a hot topic at ESRCS 2019, so we were honoured to meet with Michael Abramoff (University of Iowa) to discuss his latest research around an autonomous AI diagnostic system to assist with the diagnosis of diabetic retinopathy. Questions: 1. What are the limitations of current diagnosis of diabetic retinopathy? (0:04) 2. Could you […]
Aditya Sudhalkar, EURETINA 2019 – Latest research on the use of intravitreal steroids in DME
We met up with Aditya Sudhalkar at EURETINA 2019 to discuss his latest research into treating patients with intravitreal dexamethasone and to learn about his experiences as a rising-star in the field. Support: The production of this video was supported by Allergan, who had no involvement with the development of the content. Filmed at the […]
Samantha Fraser-Bell, EURETINA 2019 – Results of the AUSSIDEX study
Samantha Fraser-Bell (University of Sydney) caught up with us to share the latest results of the AUSSIDEX study, and discuss the real-world impact on patients with DME. Questions: 1. What are the main challenges you face when treating patients with diabetic macular oedema? (0:04) 2. Tell us about your current research in this area (0:31) […]
Antonia Joussen, EURETINA 2019 – Treating patients with large tumours
Antonia Joussen (Charité, University Medicine Berlin) shares her advice on preserving the eye when treating patients with large tumours and shares the key take-home messages of her presentations at EURETINA 2019. Questions: 1. How do you preserve eyes with large tumours? 2. What are the main take-home messages of your presentations at EURETINA 2019? Support: […]
Jost Jonas, EURETINA 2019 – A message to young ophthalmologists
Jost Jonas shares some valuable advice with early-career ophthalmologists at EURETINA 2019. Support: No funding was received in the production of this video. Jost Jonas has no financial disclosures relating to this topic.
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!